Cti Biopharma reported $18.24M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Baxter International BAX:US USD 3.77B 27M
Bristol Myers Squibb BMY:US USD 11.22B 669M
Cti Biopharma CTIC:US USD 18.24M 5.91M
Eli Lilly And LLY:US USD 6.94B 453.6M
Geron GERN:US USD 297K 224K
Mirati Therapeutics MRTX:US USD 5.43M 69K
Northwest Biotherapeutics NWBO:US USD 206K 271K
Novartis NOVN:VX USD 12.84B 243M
Novartis NVS:US USD 12.84B 243M
Seattle Genetics SGEN:US USD 510.3M 12.8M
Teva Pharmaceutical Industries TEVA:US USD 3.6B 191M
YTE INCY:US USD 823.3M 88.09M